Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials

References

• Aksenova AV, Elfimova EM, Litvin AY, Chazova IE. 2016. Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure. Systemic Hypertens. 13:37–45. doi:https://doi.org/10.26442/SG29137
   Google Scholar
• Balan H. (2009). Bedtime versus at awakening administration of BP lowering drugs – Is it the way to success? Rom J Intern Med. 47:355–361. PMID: 21179917.
   PubMedGoogle Scholar
• Baraldo M. 2008. The influence of circadian rhythyms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 4:175–192. doi: https://doi.org/10.1517/17425255.4.2.175
   PubMed Web of Science ®Google Scholar
• Beliaev SD, Zaslavskaia RM, and Khetagurova LG. 2003. Optimization of sanatorium treatment of patients with essential hypertension stage II by chronotherapy. Klin Med (Mosk). 81:46–50. PMID: 14689711.
   PubMedGoogle Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. 2007. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241. doi:https://doi.org/10.1161/HYPERTENSIONAHA.107.087262
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, et al. 2007. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet. 370:1219–1229. doi:https://doi.org/10.1016/S0140-6736(07)61538-4
   PubMed Web of Science ®Google Scholar
• Bowles NP, Thosar SS, Herzig MX, Shea SA. 2018. Chronotherapy for hypertension. Curr Hypertens Rep. 20:97. doi:https://doi.org/10.1007/s11906-018-0897-4
   PubMed Web of Science ®Google Scholar
• Charlson ME, de Moraes CG, Link A, Wells MT, Harmon G, Peterson JC, Ritch R, Liebmann JM. 2014. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology. 121:2004–2012. doi:https://doi.org/10.1016/j.ophtha.2014.04.016
   PubMed Web of Science ®Google Scholar
• De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. 2013. Circadian rhythms and medical diseases: Does it matter when drugs are taken? Eur J Intern Med. 24:698–706. doi:https://doi.org/10.1016/j.ejim.2013.03.019
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. doi:https://doi.org/10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. 2013. Dipper and non-dipper blood pressure 24-hour patterns: Circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 30:17–30. doi:https://doi.org/10.3109/07420528.2012.715872
   PubMed Web of Science ®Google Scholar
• Flack JM, Nasser SA. 2011. Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag. 7:777–787. doi:https://doi.org/10.2147/VHRM.S17207
   PubMedGoogle Scholar
• Fujiwara T, Hoshide S, Yano Y, Kanegae H, Kario K. 2017. Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension. J Clin Hypertens (Greenwich). 19:1319–1326. doi:https://doi.org/10.1111/jch.13128
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, and Aronow WS. 2021. Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol. 2021;28:e5–e8. doi:https://doi.org/10.1177/2047487320903611
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, and Aronow WS. 2020. Impact of bedtime dosing of antihypertensives compared to morning therapy: A meta-analysis of randomised controlled trials. Eur J Prev Cardiol 28 e5–e8 . doi:https://doi.org/10.1177/2047487320903611. Epub ahead of print.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE. 2016. Ambulatory blood pressure, chronotherapy of hypertension and glaucoma. Med Clin (Barc). 146:30–34. doi:https://doi.org/10.1016/j.medcli.2015.05.013
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2010a. Chronotherapy with valsartan/amlodipine fixed combination: Improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 27:1287–1303. doi:https://doi.org/10.3109/07420528.2010.489167
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010b. Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int. 27:1629–1651. doi:https://doi.org/10.3109/07420528.2010.510230
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011a. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–1173. doi:https://doi.org/10.1016/j.jacc.2011.04.043
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR. 2011b. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: Improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int. 28:601–610. doi:https://doi.org/10.3109/07420528.2011.589935
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Portaluppi F. 2007. Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 59:904–922. doi:https://doi.org/10.1016/j.addr.2006.08.003
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2016. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39:277–292. doi:https://doi.org/10.1007/s00125-015-3748-8
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2017. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Med Rev. 33:17–27. doi:https://doi.org/10.1016/j.smrv.2016.04.001
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2020a. Bedtime hypertension treatment improves cardiovascular risk reduction: The Hygia Chronotherapy Trial. Eur Heart J. 41:4565–4576. doi:https://doi.org/10.1093/eurheartj/ehz754
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171. doi:https://doi.org/10.1093/eurheartj/ehy475
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Mojón A, Smolensky MH, Fernández JR. 2021a. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations. Chronobiol Int. 38:10:1460–1476. doi:https://doi.org/10.1080/07420528.2021.1931280
   PubMedGoogle Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Crespo JJ, Otero A, Ríos MT, Domínguez-Sardiña M, Fernández JR 2020b. Does timing of antihypertensive medication dosing matter? Curr Cardiol Rep. 22(118). doi:https://doi.org/10.1007/s11886-020-01353-7
   PubMedGoogle Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2020c. Chronopharmacology of hypertension medications: Impact of ingestion-time on pharmacokinetics and pharmacodynamics. Exp Opin Drug Metab Toxicol. 16:1159–1173. doi:https://doi.org/10.1080/17425255.2020.1825681
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2021b. Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials. Adv Drug Deliv Rev. 170:200–213. doi:https://doi.org/10.1016/j.addr.2021.01.013
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Hermida-Ayala RG, Crespo JJ, Ríos MT, Domínguez-Sardiña M, Otero A, Smolensky MH. 2021c. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature. Chronobiol Int. 1–20. doi:https://doi.org/10.1080/07420528.2021.1939367. Epub ahead of print
   Google Scholar
• Hermida RC, Mojón A, Fernández JR, Otero A, Crespo JJ, Domínguez-Sardiña M, Ríos MT, Smolensky MH. 2020d. Ambulatory blood pressure monitoring-based definition of true arterial hypertension. Minerva Med. 111:573–588. doi:https://doi.org/10.23736/S0026-4806.20.06834-2
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Hermida-Ayala RG, Smolensky MH, Fernández JR. 2021d. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials. Sleep Med Rev. 59:101454. doi:https://doi.org/10.1016/j.smrv.2021.101454
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Smolensky MH, Fernández JR. 2021e. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: Controversies in hypertension – Pro side of the argument. Hypertension. 78:879–893. doi:https://doi.org/10.1161/HYPERTENSIONAHA.120.16500
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30:355–410. doi:https://doi.org/10.3109/07420528.2013.750490
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Balan H, Castriotta RJ, Crespo JJ, Dagan Y, El-Toukhy S, Fernández JR, FitzGerald GA, Fujimura A, et al. 2021f. Guidelines for the design and conduct of human clinical trials on ingestion-time differences – Chronopharmacology and chronotherapy – Of hypertension medications. Chronobiol Int. 38:1–26. doi:https://doi.org/10.1080/07420528.2020.1850468
   PubMed Web of Science ®Google Scholar
• Hoshino A, Nakamura T, Matsubara H. 2010. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 32:416–422. doi:https://doi.org/10.3109/10641961003667948
   PubMed Web of Science ®Google Scholar
• Huangfu W, Duan P, Xiang D, and Gao R. 2015. Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects. Int J Clin Exp Med. 8:19156–19161. PMID: 26770548.
   PubMed Web of Science ®Google Scholar
• Kario K, Hoshide S, Uchiyama K, Yoshida T, Okazaki O, Noshiro T, Aoki H, Mizuno H, Matsumoto Y. 2016. Dose timing of an angiotensin II receptor blocker/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation. J Clin Hypertens (Greenwich). 18:1036–1044. doi:https://doi.org/10.1111/jch.12814
   PubMed Web of Science ®Google Scholar
• Krasinska B, Karolczak-Kulesza M, Krasinski Z, Pawlaczyk-Gabriel K, Lopatka P, Gluszek J, Tykarski A. 2012. Effects of the time of antihypertensive drugs administration on the stage of primary open-angle glaucoma in patients with arterial hypertension. Blood Press. 21:240–248. doi:https://doi.org/10.3109/08037051.2012.666423
   PubMed Web of Science ®Google Scholar
• Liu X, Liu X, Huang W, Leo S, Li Y, Liu M, Yuan H. 2014. Evening – Versus morning – Dosing drug therapy for chronic kidney disease patients with hypertension: A systematic review. Kidney Blood Press Res. 39:427–440. doi:https://doi.org/10.1159/000368456
   PubMed Web of Science ®Google Scholar
• Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, et al. 2011. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol. 57:2020–2028. doi:https://doi.org/10.1016/j.jacc.2010.11.022
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang Z, Liang X, Wu C, Qi G. 2010. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 65:309–314. doi:https://doi.org/10.2143/AC.65.3.2050347
   PubMed Web of Science ®Google Scholar
• Middeke M, Klüglich M, Holzgreve H. 1991. Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: Morning versus evening dosing. Chronobiol Int. 8:506–510. doi:https://doi.org/10.3109/07420529109059186
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 151:264–269. doi:https://doi.org/10.7326/0003-4819-151-4-200908180-00135
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. 2019. Hypertension in adults: Diagnosis and management. NICE Guideline 136: Methods, evidence and recommendations. National Clinical Guidelines Centre, London, UK. Available from: https://www.nice.org.uk/guidance/ng136 [last accessed 15 August 2021].
   Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 20:2183–2189. doi:https://doi.org/10.1097/00004872-200211000-00017
   PubMed Web of Science ®Google Scholar
• Okeahialam BN, Ohihoin EN, Ajuluchukwu JN. 2012. Diuretic drugs benefit patients with hypertension more with night-time dosing. Ther Adv Drug Saf. 3:273–278. doi:https://doi.org/10.1177/2042098612459537
   PubMedGoogle Scholar
• Peng GC, Wang YF, Xiao Y, Chen JF, Yang Y, Ye YL, Sai SQ, Huang JX. (2013). Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results. Zhonghua Xin Xue Guan Bing Za Zhi. 41:484–487. PMID: 24113040.
   PubMedGoogle Scholar
• Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. 2012. Circadian rhythms and cardiovascular health. Sleep Med Rev. 16:151–166. doi:https://doi.org/10.1016/j.smrv.2011.04.003
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014a. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32:2332–2340. doi:https://doi.org/10.1097/HJH.0000000000000355
   PubMed Web of Science ®Google Scholar
• Roush GC, Fapohunda J, Kostis JB. 2014b. Evening dosing of antihypertensive therapy to reduce cardiovascular events: A third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 16:561–568. doi:https://doi.org/10.1111/jch.12354
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700. doi:https://doi.org/10.1161/HYPERTENSIONAHA.115.06981
   PubMed Web of Science ®Google Scholar
• Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. 2015. Antihypertensive drug treatment and circadian blood pressure rhythm: A review of the role of chronotherapy in hypertension. Curr Pharm Des. 21:756–772. doi:https://doi.org/10.2174/1381612820666141024130013
   PubMed Web of Science ®Google Scholar
• Skibitsky VV, Fendrikova AV, Opolskaya SV. 2018. Comparison of influence of various regimens of drug intake on 24 hour blood pressure, central aortic pressure and vascular wall stiffness in systemic hypertension patients with ischemic stroke. Russ J Cardiol. 4:56–66. doi:https://doi.org/10.15829/1560-4071-2018-4-56-66
   Google Scholar
• Skibitsky VV, Fendrikova AV, Opolskaya SV. 2019. Antihypertensive and vasoprotective effectiveness of the chronopharmacotherapy in patients with arterial hypertension after acute cerebrovascular accident. Kardiologiia. 59:25–33. doi:https://doi.org/10.18087/cardio.2537
   PubMed Web of Science ®Google Scholar
• Skibitsky VV, Fendrikova AV, Sirotenko DV, Skibitskiy AV. 2016. Chronotherapy aspects of efficiency azilsartan medoxomil in combination therapy in patients with hypertension and metabolic syndrome. Kardiologiia. 56:35–40. doi:https://doi.org/10.18565/cardio.2016.10.35-40
   Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. 2007. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680. doi:https://doi.org/10.1016/j.sleep.2006.11.011
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. 2017. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 33:4–16. doi:https://doi.org/10.1016/j.smrv.2016.02.003
   PubMed Web of Science ®Google Scholar
• Sole MJ, Martino TA. 2009. Diurnal physiology: Core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J Appl Physiol. 107:1318–1327. doi:https://doi.org/10.1152/japplphysiol.00426.2009
   PubMed Web of Science ®Google Scholar
• Sun Y, Yu X, Liu J, Zhou N, Chen L, Zhao Y, Li X, Wang J, Cui L. 2016. Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: A meta-analysis. Cardiol J. 23:473–481. doi:https://doi.org/10.5603/CJ.a2016.0027
   PubMed Web of Science ®Google Scholar
• Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. 2004. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol. 48:380–385. doi:https://doi.org/10.1007/s10384-003-0071-6
   PubMed Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 75:1334–1357. doi:https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. 2008. Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. BMJ. 336:1114–1117. doi:https://doi.org/10.1136/bmj.39553.670231.25
   PubMed Web of Science ®Google Scholar
• Werne A, Harris A, Moore D, BenZion I, Siesky B. 2008. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: Risk factors for glaucoma? Surv Ophthalmol. 53:559–567. doi:https://doi.org/10.1016/j.survophthal.2008.08.021
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmerfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 71:e127–e248. doi: https://doi.org/10.1016/j.jacc.2017.11.006.
   Google Scholar
• Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 39:3021–3104. doi:https://doi.org/10.1093/eaurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Zeng J, Jia M, Ran H, Tang H, Zhang Y, Zhang J, Wang X, Wang H, Yang C, Zeng C. 2011. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: Improved blood pressure control with bedtime dosing–a multicenter, open-label randomized study. Hypertens Res. 34:767–772. doi:https://doi.org/10.1038/hr.2011.36
   PubMed Web of Science ®Google Scholar
• Zhao P, Xu P, Wan C, Wang Z 2011. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. 10(CD004184). doi:https://doi.org/10.1002/14651858.CD004184.pub2
   Google Scholar